Detalhe da pesquisa
1.
Trial of Lixisenatide in Early Parkinson's Disease.
N Engl J Med
; 390(13): 1176-1185, 2024 Apr 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-38598572
2.
A Double-Blind, Randomized, Placebo-Controlled Trial of Bumetanide in Parkinson's Disease.
Mov Disord
; 39(3): 618-622, 2024 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-38291616
3.
Rare Missense Variants in KCNJ10 Are Associated with Paroxysmal Kinesigenic Dyskinesia.
Mov Disord
; 39(5): 897-905, 2024 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-38436103
4.
Amantadine use in the French prospective NS-Park cohort.
J Neural Transm (Vienna)
; 131(7): 799-811, 2024 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-38578434
5.
Results of a Randomized Clinical Trial of Speech After Early Neurostimulation in Parkinson's Disease.
Mov Disord
; 38(2): 212-222, 2023 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-36461899
6.
The Contribution of Subthalamic Nucleus Deep Brain Stimulation to the Improvement in Motor Functions and Quality of Life.
Mov Disord
; 37(2): 291-301, 2022 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-35112384
7.
Efficacy of Caffeine in ADCY5-Related Dyskinesia: A Retrospective Study.
Mov Disord
; 37(6): 1294-1298, 2022 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-35384065
8.
Efficacy and Safety of Electroconvulsive Therapy in Patients With Deep Brain Stimulation: Literature Review, Case Report for Patient With Essential Tremor, and Practical Recommendations.
J ECT
; 38(3): e29-e40, 2022 09 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36018735
9.
Fluoxetine for the Symptomatic Treatment of Multiple System Atrophy: The MSA-FLUO Trial.
Mov Disord
; 36(7): 1704-1711, 2021 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-33792958
10.
Excessive buccal saliva in patients with Parkinson's disease of the French COPARK cohort.
J Neural Transm (Vienna)
; 127(12): 1607-1617, 2020 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-32880023
11.
Deep brain stimulation does not enhance neuroinflammation in multiple system atrophy.
Neurobiol Dis
; 118: 155-160, 2018 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-30026036
12.
The Psychiatric Neuromodulation Unit: Implementation and Management.
J ECT
; 34(4): 211-219, 2018 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-29944606
13.
Correction to: Excessive buccal saliva in patients with Parkinson's disease of the French COPARK cohort.
J Neural Transm (Vienna)
; 128(6): 871-872, 2021 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-33084975
14.
A de novo ADCY5 mutation causes early-onset autosomal dominant chorea and dystonia.
Mov Disord
; 30(3): 423-7, 2015 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-25545163
15.
Falls in ambulatory non-demented patients with Parkinson's disease.
J Neural Transm (Vienna)
; 122(10): 1447-55, 2015 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-25845678
16.
Genome-wide association study confirms BST1 and suggests a locus on 12q24 as the risk loci for Parkinson's disease in the European population.
Hum Mol Genet
; 20(3): 615-27, 2011 Feb 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-21084426
17.
The Val158Met COMT polymorphism is a modifier of the age at onset in Parkinson's disease with a sexual dimorphism.
J Neurol Neurosurg Psychiatry
; 84(6): 666-73, 2013 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-23408064
18.
Subthalamic nucleus stimulation reverses spinal motoneuron activity in parkinsonian patients.
Brain
; 135(Pt 1): 139-47, 2012 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-22075070
19.
Nicotine in Parkinson's Disease - a Therapeutic Track Gone up in Smoke?
NEJM Evid
; 2(9): EVIDe2300167, 2023 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-38320201
20.
TMEM151A as an alternative to PRRT2 in paroxysmal kinesigenic dyskinesia: About three new cases.
Parkinsonism Relat Disord
; 108: 105295, 2023 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-36724570